NFKB1 and breast carcinoma: A study revealed that CD45+ cells, particularly tumor-associated macrophages (TAMs) and Regulatory T (TReg) cells, promote breast cancer aggressiveness through the JAK/STAT and NF-κB signaling pathways (40, 41).